Tarsus Pharmaceuticals (TARS)
(Delayed Data from NSDQ)
$41.15 USD
-0.76 (-1.81%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $41.14 -0.01 (-0.02%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth D Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TARS 41.15 -0.76(-1.81%)
Will TARS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TARS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TARS
Tarsus Pharmaceuticals (TARS) Loses -15.59% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Tops Revenue Estimates
TARS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Will Declining Medical Customers Affect Cigna's Q1 Earnings?
Wall Street Analysts See a 31.89% Upside in Tarsus Pharmaceuticals (TARS): Can the Stock Really Move This High?
Earnings Preview: Werewolf Therapeutics, Inc. (HOWL) Q1 Earnings Expected to Decline
Other News for TARS
Earnings Scheduled For August 6, 2025
Earnings To Watch: Tarsus Pharmaceuticals Inc (TARS) Reports Q2 2025 Result
Short Report: Grindr shorts at record highs as CFO quits before earnings
Deep Track Capital, LP Increases Stake in Tarsus Pharmaceuticals Inc
Tarsus to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025 | TARS ...